TELEMEDYCYNA POLSKATELEMEDYCYNA POLSKATELEMEDYCYNA POLSKA

TELEMEDYCYNA POLSKA

No trades
See on Supercharts
Market capitalization
‪14.74 M‬PLN
−0.21PLN
‪−232.20 K‬PLN
‪6.15 M‬PLN
‪9.61 M‬
Beta (1Y)
0.33

About TELEMEDYCYNA POLSKA


CEO
Lukasz Bula
Headquarters
Katowice
Founded
2005
ISIN
PLTLMDC00018
FIGI
BBG001D85G59
Telemedycyna Polska SA engages in the provision of medical treatment. It offers telecardiology services and cardiology diagnostics for individual patients as well as healthcare facilities. It operates under the brand Kardiotele. The company was founded on March 11, 2005 and is headquartered in Katowice, Poland.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of TMP is 1.38 PLN — it hasn't changed in the past 24 hours. Watch TELEMEDYCYNA POLSKA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NEWCONNECT exchange TELEMEDYCYNA POLSKA stocks are traded under the ticker TMP.
TMP stock has fallen by −6.76% compared to the previous week, the month change is a −8.61% fall, over the last year TELEMEDYCYNA POLSKA has showed a 20.00% increase.
TMP reached its all-time high on Jan 11, 2017 with the price of 3.99 PLN, and its all-time low was 0.35 PLN and was reached on Feb 28, 2020. View more price dynamics on TMP chart.
See other stocks reaching their highest and lowest prices.
TMP stock is 10.40% volatile and has beta coefficient of 0.33. Track TELEMEDYCYNA POLSKA stock price on the chart and check out the list of the most volatile stocks — is TELEMEDYCYNA POLSKA there?
Today TELEMEDYCYNA POLSKA has the market capitalization of ‪14.74 M‬, it has decreased by −3.50% over the last week.
Yes, you can track TELEMEDYCYNA POLSKA financials in yearly and quarterly reports right on TradingView.
TMP net income for the last quarter is ‪−650.20 K‬ PLN, while the quarter before that showed ‪−593.90 K‬ PLN of net income which accounts for −9.48% change. Track more TELEMEDYCYNA POLSKA financial stats to get the full picture.
No, TMP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. TELEMEDYCYNA POLSKA EBITDA is ‪−1.73 M‬ PLN, and current EBITDA margin is −15.68%. See more stats in TELEMEDYCYNA POLSKA financial statements.
Like other stocks, TMP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TELEMEDYCYNA POLSKA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TELEMEDYCYNA POLSKA technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TELEMEDYCYNA POLSKA stock shows the sell signal. See more of TELEMEDYCYNA POLSKA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.